Virax Biolabs Group Limited Receivables Turnover Ratio (VRAX), from the fourth quarter 2024 to the fourth quarter current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Virax Biolabs Group Limited  (NASDAQ: VRAX)
 

Virax Biolabs Group Limited Accounts Receivables Turnover Ratio from the fourth quarter 2024 to the fourth quarter

Quarterly Results, Trends, Rankings, Statistics


According to Virax Biolabs Group Limited Balance Sheet, in the fourth quarter 2024, company has not reported any Accounts receivable.
See Virax Biolabs Group Limited Balance Sheet

If we take a look into Healthcare sector 598 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2024 from to 3601.

What is Receivable Turnover Ratio?
What is Virax Biolabs Group Limited Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VRAX Receivables Turnover Ratio (Mar 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change - - - - -
Receivable Turnover Ratio (TTM) - - - - -
VRAX's Total Ranking # 3601 # # # #
Accounts Receivable average collection period days - - - - -
Seq. Receivable Change - - - - -
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 15
Healthcare Sector # 599
Overall Market # 3601

Receivable Turnover Ratio Statistics
High Average Low
2.59 1.33 0.07
(Mar 31 2024)  





VRAX Company Profile • Back to VRAX Efficiency Comparisons • Compare VRAX Receivables Turnover Ratio to its Competitors

Financial Statements
Virax Biolabs Group Limited's Accounts Receivable $ 0 Millions Visit VRAX's Balance sheet
Virax Biolabs Group Limited's Sales TTM $ 0 Millions Visit VRAX's Income Statement
Sources of VRAX's Revenues Visit VRAX's Sales by Geography

Other Accounts Receivable Turnover Ratios
In Vitro & In Vivo Diagnostic Substances Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VRAX's Receivable Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VRAX's Growth Rates VRAX's Roa VRAX's Inventory Turnover Ratio VRAX's Dividend Comparisons
VRAX's Profitability Ratios VRAX's Roi VRAX's Asset Turnover Ratio VRAX's Dividend Growth
VRAX's Valuation Ratios VRAX's Roe VRAX's Financial Strength Ratios VRAX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2024 Receivable at quarter ending Mar 31 2024

Date modified: 2024-10-22T17:06:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.